ArticleExperimental and therapeutic medicine2017

Comparison of effectiveness and adverse effects of gefitinib, erlotinib and icotinib among patients with non-small cell lung cancer: A network meta-analysis.

Yuanyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.